Green Cross Health Ltd · NZX:GXH
Green Cross Health — FY2020 Earnings Presentation
20 slides from Green Cross Health's earnings presentation, Jun 25, 2020
Slide 1: GXH Annual Results Presentation 25 June 2020
GXH Annual Results Presentation 25 June 2020 Pg 1
Slide 2: GXH Annual Result - Financial Highlights
GXH Annual Result - Financial Highlights Revenue Pharmacy $568.5m 0.2% Same store sales 1.5% Operating Profit/EBIT Medical Operating Profit $31.0m¹ 5.5% $8.0m3 81.1% Net Profit After Tax Community Health $13.5m² -16.2% Operating Profit (attributable to shareholders) $2.5m +$2.4m Note: 1 Net operatin
Slide 3: Our Purpose
Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Annual Results Presentation 25 June 2020 Pg 3
Slide 4: Who we are
Who we are GXH Annual Results Presentation 25 June 2020 Pg 4
Slide 5: Pharmacy Division
Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care GXH Annual Results Presentation 25 June 2020 Pg 5
Slide 6: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue Pharmacy Operating Profit $m $m 350 32 28.9 27.9 27.3 341.3 340.2 28 340 336.4 22.5 24 330 20 322.6 16 320 12 8 310 4 300 0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 Adjustment • Revenue down 1% at $336.4m, following prior period store closures a
Slide 7: Pharmacy Future Focus
Pharmacy Future Focus Retail Disciplines • Evolve retail offering to changing consumer behaviour post COVID-19 • Focus on margin management Customer Engagement • Strengthen digital capability around 1.7m Living Rewards database • Grow e-commerce • Advocate for removal of $5 prescription co-payment t
Slide 8: Medical Division
Medical Division Growth, leadership and sustainable models of care GXH Annual Results Presentation 25 June 2020 Pg 8
Slide 9: Medical Performance
Medical Performance Medical Operating Revenue Medical Operating Profit $m $m 90 9 8.0 80 76.5 8 70.5 70 7 60 52.7 6 49.3 50 5 4.4 40 4 3.7 2.9 30 3 20 2 10 1 0 0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 adjustment • Revenue up 8.5% to $76.5m, primarily as a result of organic growth • Operatin
Slide 10: Medical Future Focus
Medical Future Focus Network Scale • Continue to build The Doctors brand • Network and patient number growth through targeted acquisitions and organic revenue growth Patient Engagement • Deploy digital technology to increase efficiency and enhance delivery of high quality patient care • Work closely
Slide 11: Community Health Division
Community Health Division Delivering sustainable services to maintain and support clients’ independence within their own home GXH Annual Results Presentation 25 June 2020 Pg 11
Slide 12: Community Health Performance
Community Health Performance Community Health Operating Revenue Community Health Operating Profit $m $m 180 3.5 156.5 155.6 3.0 160 143.2 3.0 140 2.5 115.7 2.5 120 100 2.0 80 1.5 1.2 60 1.0 40 20 0.5 0.1 0 0.0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 adjustment • Revenue down 0.5% to $155.6m
Slide 13: Community Health Future Focus
Community Health Future Focus Service Offering • Focus on higher clinical needs segments • Expand geographic coverage of Community Nursing business Digital Communication • Harness technology to enhance workforce efficiency and client outcomes Financial Returns • Continue cost reduction initiatives •
Slide 14: Group Financial Result
Group Financial Result 12 months ending 31 March 2020 GXH Annual Results Presentation 25 June 2020 Pg 14
Slide 15: Year End Result - Group Revenue and Profit
Year End Result - Group Revenue and Profit GXH Operating Revenue GXH Operating Profit $m $m 600 40 34.9 567.2 568.5 35 30.0 31.0 29.4 550 537.2 30 25 500 487.6 20 15 450 10 5 400 0 2017 2018 2019 2020 2017 2018 2019 2020 IFRS 16 Adjustment • Revenue of $569m flat year on year • Operating Profit of $
Slide 16: Net Profit After Tax (attributable to shareholders)
Net Profit After Tax (attributable to shareholders) GXH Net Profit after Tax Attributable to Shareholders $m 20.0 17.0 15.6 16.1 14.1 15.0 13.5 10.0 5.0 0.0 2017 2018 2019 2020 IFRS 16 Adjustment • NPAT attributable to shareholders of $13.5m, down 16.2% • NPAT attributable to shareholders of $14.1m
Slide 17: Operating Cash / Investments
Operating Cash / Investments GXH Operating Cash Flow $m 60 54.3 • Operating Cash of $54.3m ($34.8m before the 55 application of IFRS 16) 50 45 40 Enabling investment ($10.8m) in: 35 33.1 31.4 • Drury Surgery (new holding) 29.9 30 • Karori pharmacies (two new holdings) 25 • Waiuku Medical Pharmacy (i
Slide 18: Net Debt / Debt Capacity
Net Debt / Debt Capacity Net Debt (Borrowings Less Cash) $m 0 2017 2018 2019 2020 • $10m improvement in Net Debt to $22.6m -5 • Debt facilities with BNZ mature 22 August 2022 -10 • $10m of headroom on BNZ group debt facility -15 • Strong Balance Sheet will help absorb COVID-19 -20 and economic downt
Slide 19: Earnings Per Share
Earnings Per Share Earnings Per Share Cps 16 14.18 14 • EPS at 9.42 cps (9.85 cps before the 12 application of IFRS 16) 11.02 11.25 9.85 10 9.42 8 6 4 2 0 2017 2018 2019 2020 IFRS 16 adjustment GXH Annual Results Presentation 25 June 2020 Pg 19
Slide 20: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability